Actualités

Over the past six months, STERIS’s stock price fell to $214.47. Shareholders have lost 11.3% of their capital, which is disappointing considering the S&P 500 has climbed by 6.4%. This may have investors wondering how to approach the situation.

EchoStar has been on fire lately. In the past six months alone, the company’s stock price has rocketed 67.6%, reaching $123.16 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.

Advanced Micro Devices is expected to post strong growth driven by AI data center demand, though pricing pressure could weigh on margins.

Communications chips maker Qorvo (NASDAQ: QRVO) will be reporting results this Tuesday after market close. Here’s what to expect.

Apple’s Q2 earnings report gave Wall Street a lot to like. Bank of America analysts were all praise for the Cupertino giant’s performance, giving them enough confidence to raise their price target to $330 (18% higher than current prices), while keeping a buy rating. Q2 was another massive ...

Palantir's first quarter was nothing short of astounding. But does it live up to its sky-high valuation?

V2X (NYSE:VVX) executives highlighted double-digit growth, record bookings, and a higher full-year outlook during the company’s first-quarter 2026 earnings call, pointing to continued demand across its portfolio of mission support, aerospace, and training capabilities. First-quarter results show re

Pinterest (NYSE:PINS) reported stronger-than-expected first-quarter 2026 results and emphasized ongoing efforts to translate growing engagement into more consistent monetization, driven by AI-powered product improvements, measurement upgrades, and changes to its go-to-market organization. Q1 result

IREN Ltd. (NASDAQ:IREN) is one of the 10 Stocks Exploding in a Bleeding Market. IREN extended its winning streak to a third straight day on Monday, jumping 8.37 percent to finish at $49.48 apiece, as investors resumed buying positions ahead of the results of its earnings performance. In a notice to investors, IREN Ltd. (NASDAQ:IREN) […]

Fabrinet (NYSE:FN) reported record fiscal third-quarter results as management pointed to accelerating demand across parts of its optical and non-optical portfolio, while also flagging component shortages that limited Datacom shipments. Quarterly results topped guidance as growth accelerated Chairma

Grab (NASDAQ:GRAB) opened 2026 with what management described as a strong first quarter despite typical seasonal softness tied to Ramadan and Chinese New Year, pointing to accelerating on-demand growth, continued profitability improvements, and expanding use of artificial intelligence across its pla

BWX Technologies (NYSE:BWXT) reported what President and CEO Rex Geveden called “a great start to 2026,” posting first-quarter results that came in ahead of management expectations and were supported by higher throughput, favorable pacing of work, and operational execution across business lines. Fi

Oil and gas producer Kosmos Energy (NYSE:KOS) will be announcing earnings results this Tuesday before market hours. Here’s what you need to know.

Global pharmaceutical company Pfizer (NYSE:PFE) will be reporting results this Tuesday before the bell. Here’s what investors should know.

Moby summary of Vertex Pharmaceuticals Incorporated's Q1 2026 earnings call

Moby summary of ThredUp Inc.'s Q1 2026 earnings call

Grab (GRAB) delivered earnings and revenue surprises of -133.33% and +1.77%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Moby summary of Ichor Holdings, Ltd.'s Q1 2026 earnings call

Moby summary of Fabrinet's Q3 2026 earnings call

Moby summary of Firefly Aerospace Inc.'s Q1 2026 earnings call

Moby summary of Evolus, Inc.'s Q1 2026 earnings call

Moby summary of ON Semiconductor Corporation's Q1 2026 earnings call

Moby summary of Duolingo, Inc.'s Q1 2026 earnings call

Moby summary of Adeia Inc.'s Q1 2026 earnings call

Moby summary of Pinterest, Inc.'s Q1 2026 earnings call

Vertex Pharmaceuticals (NASDAQ:VRTX) reported first-quarter 2026 total revenue of $2.99 billion, up 8% year over year, as growth in its cystic fibrosis (CF) franchise and contributions from newer launches helped drive results. CEO and President Dr. Reshma Kewalramani said the company is “off to a te

The headline numbers for Grab (GRAB) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Oil prices fell as wary markets monitored a fragile US-Iran ceasefire in the wait for the latest rush of earnings.

Major gauges traded close to flat as investors adjusted to news that ships in the Strait of Hormuz had been struck with missiles.

Voyager Technologies, Inc. (VOYG) delivered earnings and revenue surprises of +7.22% and -1.00%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?